Incorporating Quality Assurance in Pharmaceutical Compounding-related Courses in the PharmD Curricula.


Journal

International journal of pharmaceutical compounding
ISSN: 1092-4221
Titre abrégé: Int J Pharm Compd
Pays: United States
ID NLM: 9706294

Informations de publication

Date de publication:
Historique:
entrez: 11 7 2020
pubmed: 11 7 2020
medline: 16 7 2020
Statut: ppublish

Résumé

The art and the skill set of compounding fulfill the important need of tailor-made pharmaceuticals for use by both institutions and individual  patients. Over the last 20 years, there have been more than 200 adverse events involving compounded products; infections, poisonings, contaminations, and dosing inaccuracies have been problematic. The probability of a correlation between the lack of institutional training and number of serious events could be significant. This survey was an endeavor at fundamental cause analysis and proactive management in relation to the PharmD Curricula as a means of error prevention. A questionnaire was sent to the pharmacy school faculty (department chairs, dean/assistant deans, and pharmaceutical science faculty) across the country. The survey responses were received from 78 participants. The questionnaire evaluated the respondent's overall knowledge and approach toward the subject in their curriculum. The survey results show 38.9% faculty agree that their college's curricula lacks sufficient training in microbiological testing, and 16.7% faculty agree their college does not provide sufficient training in nonsterile and sterile compounding (as per United States Pharmacopeia Chapters <795> and <797>). A majority of faculty agree on the implementation of quality assurance in compounding courses (as per United States Pharmacopeia Chapter  <1163>) as either an elective (62.5%) or mandatory class (43.3%), and most of the participants (85.1%) think there is a need to teach quality assurance as continuing education to practicing pharmacists. The survey data suggest a general desire for enhancement of compounding course curriculum, which could reduce the number of adverse events related to compounding. The data also suggests a necessity for the implementation of continuing education programs for practicing pharmacists and academic faculty across the country.

Identifiants

pubmed: 32649305

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

322-326

Informations de copyright

Copyright© by International Journal of Pharmaceutical Compounding, Inc.

Auteurs

Mohammad Faisal Hossain (MF)

Appalachian College of Pharmacy, Oakwood, Virginia. mhossain@acp.edu.

Dan Levesque (D)

Appalachian College of Pharmacy, Oakwood, Virginia.

John Frye (J)

Appalachian College of Pharmacy, Oakwood, Virginia.

Mamoon Rashid (M)

Appalachian College of Pharmacy, Oakwood, Virginia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH